{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:35:38Z","timestamp":1776414938026,"version":"3.51.2"},"reference-count":49,"publisher":"Wiley","issue":"15","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100007155","name":"Medical Research Council Canada","doi-asserted-by":"publisher","award":["MT\u201011086"],"award-info":[{"award-number":["MT\u201011086"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1999,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Hereditary tyrosinemia type I is the most severe metabolic disease of the tyrosine catabolic pathway mainly affecting the liver. It is caused by deficiency of fumarylacetoacetate hydrolase, which prevents degradation of the toxic metabolite fumarylacetoacetate (FAA). We report here that FAA induces common effects (i.e., cell cycle arrest and apoptosis) in both human (HepG2) and rodent (Chinese hamster V79) cells, effects that seem to be temporally related. Both the antiproliferative and apoptosis\u2010inducing activities of FAA are dose dependent and enhanced by glutathione (GSH) depletion with L\u2010buthionine\u2010(S,R)\u2010sulfoximine (BSO). Short treatment (2 h) with 35 \u00b5M FAA\/+BSO or 100 \u00b5M FAA\/\u2014BSO induced a transient cell cycle arrest at the G2\/M transition (20% and 37%, respectively) 24 h post\u2010treatment. In cells treated with 100 \u00b5M FAA\/\u2013BSO, an inactivation, followed by a rapid over\u2010induction of cyclin B\u2010dependent kinase occurred, which peaked 24 h post\u2010treatment. Maximum levels of caspase\u20101 and caspase\u20103 activation were detected at 3 h and 32 h, respectively, whereas release of mitochondrial cytochrome\n                    <jats:italic>c<\/jats:italic>\n                    was maximal at 24\u201332 h post\u2010treatment. The G2\/M peak declined 24 h later, concomitantly with the appearance of a sub\u2010G1, apoptotic population showing typical nucleosomal\u2010sized DNA fragmentation and reduced mitochondrial transmembrane potential (\u0394\u03c8\n                    <jats:sub>m<\/jats:sub>\n                    ). These events were prevented by the general caspase inhibitor z\u2010VAD\u2010fmk, whereas G2\/M arrest and subsequent apoptosis were abolished by GSH\u2010monoethyl\u2010ester or\n                    <jats:italic>N<\/jats:italic>\n                    \u2010acetylcysteine. Other tyrosine metabolites, maleylacetoacetate and succinylacetone, had no antiproliferative effects and induced only very low levels of apoptosis. These results suggest a modulator role of GSH in FAA\u2010induced cell cycle disturbance and apoptosis where activation of cyclin B\u2010dependent kinase and caspase\u20101 are early events preceding mitochondrial cytochrome\n                    <jats:italic>c<\/jats:italic>\n                    release, caspase\u20103 activation, and \u0394\u03c8\n                    <jats:sub>m<\/jats:sub>\n                    loss.\u2014Jorquera, R., Tanguay, R. M. Cyclin B\u2010dependent kinase and caspase\u20101 activation precedes mitochondrial dysfunction in fumarylacetoacetate\u2010induced apoptosis.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    13, 2284\u20132298 (1999)\n                  <\/jats:p>","DOI":"10.1096\/fasebj.13.15.2284","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T04:15:54Z","timestamp":1516853754000},"page":"2284-2298","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cyclin B\u2010dependent kinase and caspase\u20101 activation precedes mitochondrial dysfunction in fumarylacetoacetate\u2010induced apoptosis"],"prefix":"10.1096","volume":"13","author":[{"given":"ROSSANA","family":"JORQUERA","sequence":"first","affiliation":[{"name":"Laboratory of Cell and Developmental Genetics Department of Medicine Universit\u00e9 Laval and CHUL Research Center Ste\u2010Foy Quebec Canada G1K 7P4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT M.","family":"TANGUAY","sequence":"additional","affiliation":[{"name":"Laboratory of Cell and Developmental Genetics Department of Medicine Universit\u00e9 Laval and CHUL Research Center Ste\u2010Foy Quebec Canada G1K 7P4"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1999,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.10.4641"},{"key":"e_1_2_6_3_1","first-page":"308","article-title":"Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I)","volume":"47","author":"Tanguay R. M.","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115979"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9"},{"key":"e_1_2_6_6_1","first-page":"1077","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Mitchell G. A.","year":"1995"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)80259-4"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1203\/00006450-198412000-00023","article-title":"Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency","volume":"18","author":"Stoner E.","year":"1985","journal-title":"Pediatr. Res."},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4613-1835-4_17","volume-title":"Essential Nutrients in Carcinogenesis","author":"Laberge C.","year":"1986"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.18388\/abp.1996_4530"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6220"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.39.24426"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9552"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.6.8.1430"},{"key":"e_1_2_6_15_1","first-page":"292","article-title":"Enzymes involved in conversion of tyrosine to acetoacetate","volume":"2","author":"Edwards S. W.","year":"1955","journal-title":"Methods Enzymol."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(90)90313-Y"},{"key":"e_1_2_6_17_1","first-page":"3186","article-title":"The cell cycle related differences in susceptibility of HL\u201060 cells to apoptosis induced by various antitumor agents","volume":"53","author":"Gorczyca W.","year":"1993","journal-title":"Cancer Res."},{"key":"e_1_2_6_18_1","first-page":"3.17.1","article-title":"Morphological and biochemical assays of apoptosis","volume":"1","author":"Duke R. C.","year":"1992","journal-title":"Curr. Prot. Immunol."},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1994.1184"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240590310"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5303.1132"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15632.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990130802"},{"key":"e_1_2_6_24_1","first-page":"3697","article-title":"Involvement of NAD\u2010poly(ADP\u2010ribose) metabolism in p53 regulation and its consequences","volume":"55","author":"Whitacre C.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/344503a0"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.44.27847"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.10.2926"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/371346a0"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.11.7223"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3150021"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.5.2912"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.144.2.281"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80085-9"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.15.4639"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.5.1207"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.1.37"},{"key":"e_1_2_6_37_1","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/emboj\/16.10.2794","article-title":"FLICE is activated by association with the CD95 death\u2010inducing signaling complex (DISC)","author":"Medema J. P.","year":"1997","journal-title":"EMBO J. 16"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8108732"},{"key":"e_1_2_6_39_1","first-page":"4551","article-title":"Requirement of p34cdc2 kinase for apoptosis mediated by the Fas\/APO\u20101 receptor and interleukin 1 \u03b2\u2010converting enzyme\u2010related proteases","volume":"56","author":"Yao S.\u2010L.","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_6_40_1","first-page":"983","article-title":"The role of cell cycle progression in cisplatin\u2010induced apoptosis in Chinese hamster ovary cells","volume":"5","author":"Demarcq C.","year":"1994","journal-title":"Cell Growth Differ."},{"key":"e_1_2_6_41_1","first-page":"228","article-title":"Unscheduled activation of cyclin B1\/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage","volume":"55","author":"Shimizu T.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_42_1","first-page":"43","article-title":"Relationships between cdc2 kinase, {pg=} DNA cross\u2010linking, and cell cycle perturbations induced by nitrogen mustard","volume":"3","author":"O\u2019Connor P.","year":"1992","journal-title":"Cell Growth Differ."},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240540411"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5331.1495"},{"key":"e_1_2_6_45_1","first-page":"5168","article-title":"The role of cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells","volume":"57","author":"Poon R. Y. C.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3706"},{"key":"e_1_2_6_47_1","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.4049\/jimmunol.161.12.6689","article-title":"Redox regulation of caspase\u20103(\u2010like) protease activity: regulatory roles of thioredoxin and cytochromec","volume":"161","author":"Ueda S.","year":"1998","journal-title":"J. Immunol."},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.2956"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.21.12614"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/09553008114551311"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.13.15.2284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fasebj.13.15.2284","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.13.15.2284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T22:43:56Z","timestamp":1761691436000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.13.15.2284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":49,"journal-issue":{"issue":"15","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1096\/fasebj.13.15.2284"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.13.15.2284","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]},"assertion":[{"value":"1999-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}